Abbott recently launched the International Cardio‑Renal Risk Assessment and Stratification (ICRAS) Tool in India. This diabetes cardio-renal risk tool helps doctors identify heart and kidney risks early in patients with Type 2 Diabetes Mellitus (T2DM). Early identification is crucial because India currently has over 101 million people living with diabetes. Consequently, clinicians need better ways to predict complications before they become severe. Physicians looking to deepen their knowledge in this area might benefit from the International Post Graduate Program In Diabetes Mellitus Management.
The Importance of a Diabetes Cardio-Renal Risk Tool
India is often called the diabetes capital of the world. Heart and kidney conditions are the most serious complications for those with Type 2 diabetes. For instance, chronic kidney disease affects roughly 40% of these patients. Additionally, nearly one-third of people with T2DM suffer from some form of heart disease. Many complications develop silently, so patients might feel fine while damage occurs. Therefore, using a specialized tool allows for timely interventions. This approach can significantly slow the progression of serious health issues. Understanding cardiovascular risk factors is central to managing this epidemic, which is covered in detail in our Postgraduate Diploma In Preventative Cardiovascular.
How the ICRAS Tool Works
The web-based ICRAS tool utilizes medical test results and lifestyle factors to generate risk scores. Specifically, it assesses the likelihood of developing Diabetic Kidney Disease (DKD) and Coronary Heart Disease (CHD). It also predicts Major Adverse Cardiovascular Events (MACE). Furthermore, the tool accounts for gender-specific differences to offer personalized summaries. Clinicians can use these scores to make evidence-based decisions. Importantly, the tool ensures privacy by not capturing any personal data of doctors or patients. This makes the assessment process both secure and efficient. For clinicians focused on chronic disease management, the Certification Course In Diabetes And Metabolic Disorder Care provides essential skills.
Frequently Asked Questions
Q1: What specific conditions does the ICRAS tool evaluate?
The tool generates separate risk scores for Diabetic Kidney Disease (DKD), Coronary Heart Disease (CHD), and Major Adverse Cardiovascular Events (MACE).
Q2: Is patient data stored within the ICRAS web-based tool?
No, the tool is designed with privacy at its core. It does not capture or store any personal information regarding patients or clinicians.
References
- Abbott Launches ICRAS Tool to Enable Early Identification of Diabetes RelatedHeart and Kidney Risks – ETHealthworld
- indiatimes.com – Diabetes and Kidney Disease: Hidden Heart Attack Risks (2026)
- newindianexpress.com – India tops Asia-Pacific in type-2 diabetes deaths (2026)
Disclaimer: This article was automatically generated from publicly available sources and is provided for informational and educational purposes only. OC Academy does not exercise editorial control or claim authorship over this content. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider and refer to current local and national clinical guidelines.